122 related articles for article (PubMed ID: 37533483)
1. Evaluation of serum complement C4 among COVID-19 patients in Khartoum state: a case control-based study.
Yahya M; Rahamtalla YA; Mohammed Nasr N; Gorish BMT
F1000Res; 2023; 12():432. PubMed ID: 37533483
[No Abstract] [Full Text] [Related]
2. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
3. Complement Levels in Nigeria Patients with Sickle Cell Anaemia in the Asymptomatic State.
Okeke TI; P Musa BO; Babadoko AA; Jamoh BY
Niger J Clin Pract; 2018 Sep; 21(9):1139-1143. PubMed ID: 30156198
[TBL] [Abstract][Full Text] [Related]
4. Complement components (C3, C4) as inflammatory markers in asthma.
Abdel Fattah M; El Baz M; Sherif A; Adel A
Indian J Pediatr; 2010 Jul; 77(7):771-3. PubMed ID: 20589464
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of complement C3 and C4 in dogs with idiopathic epilepsy.
Kang S; Koo Y; Yun T; Chae Y; Lee D; Kim H; Yang MP; Kang BT
J Vet Intern Med; 2024; 38(2):1074-1082. PubMed ID: 38329151
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID-19.
Bagherimoghaddam A; Rafatpanah H; Mansouritorghabeh H
Health Sci Rep; 2022 Mar; 5(2):e519. PubMed ID: 35224220
[TBL] [Abstract][Full Text] [Related]
8. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.
Ritchie RF; Palomaki GE; Neveux LM; Navolotskaia O; Ledue TB; Craig WY
J Clin Lab Anal; 2004; 18(1):1-8. PubMed ID: 14730550
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum C3/C4 ratio and prognosis of immunoglobulin A nephropathy based on propensity score matching.
Zhang Y; Duan SW; Chen P; Yin Z; Wang Y; Cai GY; Chen XM
Chin Med J (Engl); 2020 Mar; 133(6):631-637. PubMed ID: 32068601
[TBL] [Abstract][Full Text] [Related]
10. Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris.
Giasuddin AS; ElMahdawi JM; ElHassadi FM
Bangladesh Med Res Counc Bull; 2007 Dec; 33(3):98-102. PubMed ID: 18783065
[TBL] [Abstract][Full Text] [Related]
11. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects.
Yang X; Sun J; Gao Y; Tan A; Zhang H; Hu Y; Feng J; Qin X; Tao S; Chen Z; Kim ST; Peng T; Liao M; Lin X; Zhang Z; Tang M; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Trent JM; Zheng SL; Xu J; Mo Z
PLoS Genet; 2012 Sep; 8(9):e1002916. PubMed ID: 23028341
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
Li H; Lin S; Yang S; Chen L; Zheng X
Clin Rheumatol; 2015 Mar; 34(3):471-7. PubMed ID: 25597615
[TBL] [Abstract][Full Text] [Related]
15. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
16. [Hypocomplementaemia in children with chronic viral hepatitis as a risk factor for invasive encapsulated bacteria infection].
Pokorska-Lis M; Kowalik-Mikołajewska B; Aniszewska M
Med Wieku Rozwoj; 2008; 12(2 Pt 2):693-7. PubMed ID: 19418946
[TBL] [Abstract][Full Text] [Related]
17. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
Li L; Chen C
Epidemiol Infect; 2020 Jul; 148():e164. PubMed ID: 32713370
[TBL] [Abstract][Full Text] [Related]
18. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
[TBL] [Abstract][Full Text] [Related]
19. Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: further evidence of inflammatory activation.
Sampietro T; Bigazzi F; Dal Pino B; Rossi G; Chella E; Lusso S; Puntoni M; Tuoni M; Bionda A
Heart; 2004 Dec; 90(12):1438-42. PubMed ID: 15547024
[TBL] [Abstract][Full Text] [Related]
20. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
Ward M; Eastwood MA
Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
